Latest Posts



Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More


Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

D4: Data-Driven Drug Development

D4: Data-Driven Drug Development is the first conference to specifically help pharma and biotech companies build and execute a scalable, sustainable, and future-resistant R&D data strategy, including innovative yet accessible new approaches, methods, and ways of looking at the data life cycle that drive incredible value within pharma R&D.

D4: Pharma is a highly-select gathering of 80-100 very senior, experienced pharma professionals who are responsible for making important decisions, changes, and turning innovation and new ideas into measurable progress. An incredible place for focused learning, intelligence gathering and senior-level networking.

When: 20-21 March, 2019
Where: USA, Cambridge, Sheraton Commander Hotel

Meet Lawrence Ganti, President of Life Science & CEO Innoplexus, at the conference. He will speak at 10 am, March 20th about:

“Practical Application of AI in Pharma”.

There has been significant buzz and hype around AI in Pharma. With reports of many failures and below expectation deliveries, this presentation hopes to share what are some real practical applications of AI and what elements of AI matter when it comes to the specifics of life sciences.

See full Agenda.

Meet us at D4: Data-Driven Drug Development


Lawrence Ganti, CEO, Life Sciences, Innoplexus.